🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study is being conducted to evaluate the safety, tolerability and effic...
Status
Recruiting
Location
Shanxi Cancer hospital
Start Date
2025-03-28
Trial ID
NCT06895928
This study is a randomized, open-label, controlled, multicenter Phase II tr...
Status
Not Yet Recruiting
Location
Fudan University Shanghai Cancer center
Start Date
2026-06
Trial ID
NCT07581795
This study is a multicentre, open-label, dose-finding/efficacy-expanding ph...
Status
Recruiting
Location
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Start Date
2025-04-25
Trial ID
NCT06859775
This study is a phase I clinical trial of multi-center, open label, dose in...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2025-09-07
Trial ID
NCT07348042
Treatments Being Tested
This study is a multicenter, open-label, dose-finding/efficacy-expanding Ph...
Status
Recruiting
Location
Shanghai Chest Hospital
Start Date
2024-09-27
Trial ID
NCT06589778
Treatments Being Tested
The primary objective of this study is to evaluate the pathological respons...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2025-03-20
Trial ID
NCT07336979
Treatments Being Tested
1. Evaluation of adebelimab in combination with irinotecan liposomes, oxali...
Status
Recruiting
Location
Shanghai General Hospital
Start Date
2024-07-16
Trial ID
NCT06531278
Treatments Being Tested
A study of adebelimab in combination with chemotherapy in the first-line tr...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-02-01
Trial ID
NCT06614621
Treatments Being Tested